文献速递脊柱关节炎

银屑病关节炎难治与复杂管理表型的患病率及临床负担:SCQM注册研究

Difficult-to-manage psoriatic arthritis: Prevalence, phenotype, and clinical burden in real-world practice: insights from the SCQM registry.
PubMed 文献 · Semin Arthritis Rheum · 2026-10-21

基于瑞士SCQM前瞻性多中心纵向注册数据,对2493例启动先进治疗且随访≥12个月的银屑病关节炎患者回顾性应用GRAPPA与EULAR的C2M/D2M及TR定义。结果显示30.4%/2.6%符合GRAPPA的C2M/TR标准,17%/7.3%符合EULAR的D2M/TR标准。C2M/D2M患者女性、吸烟、高BMI及共病更多,炎症标志物、附着点炎、中轴受累、皮损严重度及疾病活动度更高,提示需表型分层管理。

要点

  • GRAPPA标准下C2M占30.4%、TR占2.6%;EULAR标准下D2M占17%、TR占7.3%。
  • C2M/D2M患者女性、吸烟、高BMI及共病比例更高(p<0.001)。
  • C2M/D2M患者炎症标志物、附着点炎、中轴受累及疾病活动度更高(p≤0.001)。

核心结论

  • 在真实世界队列中应用GRAPPA与EULAR定义可识别出临床与炎症特征不同的C2M/D2M及TR亚组,提示需表型定制管理策略。

研究设计与样本

  • 回顾性分析瑞士SCQM前瞻性、多中心、纵向注册数据,纳入注册后启动先进治疗且随访≥12个月的患者。

主要发现

  • 2493例患者中30.4%符合GRAPPA的C2M标准、2.6%符合TR标准;17%符合EULAR的D2M标准、7.3%符合TR标准。
  • C2M/D2M患者较非C2M/非D2M者女性更多(p<0.001)、吸烟及高BMI更多、共病更多。
  • C2M/D2M患者炎症标志物、附着点炎、中轴受累、皮损严重度及疾病活动度评分更高(p≤0.001)。
  • HLA-B27、指趾炎、甲病变及其他肌肉骨骼外表现在C2M/D2M与非C2M/非D2M间无显著差异。
  • 两种标准下TR亚组均显示更高BMI、肿胀关节计数及压痛附着点;D2M-TR患者炎症标志物、生活质量及疾病活动度与非TR的D2M患者有显著差异(p<0.05)。

关键数值与推荐

  • GRAPPA标准:C2M占30.4%,TR占2.6%。
  • EULAR标准:D2M占17%,TR占7.3%。
  • C2M/D2M与非C2M/非D2M比较:女性比例p<0.001,炎症标志物、附着点炎、中轴受累、皮损严重度及疾病活动度p≤0.001。
  • D2M-TR与非TR的D2M比较:炎症标志物、生活质量及疾病活动度p<0.05。

临床怎么用

  • 对启动先进治疗后的银屑病关节炎患者,可依据GRAPPA或EULAR定义识别C2M/D2M及TR表型。
  • 对女性、吸烟、高BMI、共病多及炎症标志物/附着点炎/中轴受累突出的患者,需关注其复杂管理风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To apply consensus-based, difficult-to-treat definitions of psoriatic arthritis (PsA) and to investigate the prevalence, demographics, and clinical characteristics of difficult-to-manage (D2M)/complex-to-manage (C2M) and treatment-refractory (TR) PsA. METHODS: Retrospective analysis of data derived from the prospective, multicentre, longitudinal Swiss registry was conducted. Patients were eligible if they initiated their advanced therapy after inclusion in the registry and had ≥12 months of follow-up. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) and European Alliance of Associations for Rheumatology (EULAR) definitions were applied to identify cases of C2M/D2M and TR. RESULTS: From 2493 patients, 30.4% / 2.6% fulfilled the GRAPPA criteria for C2M/TR disease, while 17% / 7.3% met the D2M/TR EULAR criteria, respectively. At baseline, C2M/D2M patients were more frequently women (p < 0.001), smokers, had higher body mass index (BMI), and presented more comorbidities. C2M/D2M patients also demonstrated higher inflammatory markers, higher prevalence of enthesitis, more axial involvement, more severe psoriasis, and worse disease activity scores compared with non-C2M/non-D2M patients (p ≤ 0.001). However, there were no significant differences regarding the prevalence of HLA-B27, dactylitis, nail disease, or other extra-musculoskeletal manifestations. Within both criteria, the TR subgroup showed higher BMI, swollen joint counts, and tender entheses. D2M-TR patients showed significant differences regarding the inflammatory markers, quality of life, and disease activity measures, compared to non-TR D2M patients (p < 0.05). CONCLUSION: Applying the GRAPPA and EULAR definitions in a large real-world cohort identified distinct clinical and inflammatory profiles in the C2M/D2M and TR groups, highlighting the need for phenotype-tailored management strategies.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Elsehrawy GG, Courvoisier DS, Brülhart-Bletsas L, et al. Difficult-to-manage psoriatic arthritis: Prevalence, phenotype, and clinical burden in real-world practice: insights from the SCQM registry. Semin Arthritis Rheum. 2026. PMID: 42956546. doi:10.1016/j.semarthrit.2026.153089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。